View in EDS HTML Full Text PDF Full Text

Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes.

Saved in:
Bibliographic Details
Title: Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes.
Authors: Chen YH; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan.; Division of Rheumatology, Immunology and Allergy, Department of Medicine, School of Medicine, College of Medicine, National Defense Medical University, Taipei, Taiwan., Byers Kraus V; Department of Medicine, Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA., Chang YS; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan., Lin TM; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan., Lee HY; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan., Chang CK; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan., Kuo TT; Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, Taipei City, Taiwan., Chen JH; Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, Taipei City, Taiwan.; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei City, Taiwan., Chang CC; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 252, Wu Hsing Street, Taipei City 110, Taiwan.; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
Source: Therapeutic advances in musculoskeletal disease [Ther Adv Musculoskelet Dis] 2026 Mar 29; Vol. 18, pp. 1759720X261434279. Date of Electronic Publication: 2026 Mar 29 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101517322 Publication Model: eCollection Cited Medium: Print ISSN: 1759-720X (Print) Linking ISSN: 1759720X NLM ISO Abbreviation: Ther Adv Musculoskelet Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41919008
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chen+YH%22">Chen YH</searchLink>; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan.; Division of Rheumatology, Immunology and Allergy, Department of Medicine, School of Medicine, College of Medicine, National Defense Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Byers+Kraus+V%22">Byers Kraus V</searchLink>; Department of Medicine, Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Chang+YS%22">Chang YS</searchLink>; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+TM%22">Lin TM</searchLink>; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lee+HY%22">Lee HY</searchLink>; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chang+CK%22">Chang CK</searchLink>; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Kuo+TT%22">Kuo TT</searchLink>; Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+JH%22">Chen JH</searchLink>; Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, Taipei City, Taiwan.; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chang+CC%22">Chang CC</searchLink>; Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 252, Wu Hsing Street, Taipei City 110, Taiwan.; Division of Rheumatology, Immunology and Allergy, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101517322%22">Therapeutic advances in musculoskeletal disease</searchLink> [Ther Adv Musculoskelet Dis] 2026 Mar 29; Vol. 18, pp. 1759720X261434279. <i>Date of Electronic Publication: </i>2026 Mar 29 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101517322 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1759-720X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221759720X%22">1759720X </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Musculoskelet Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41919008
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/1759720X261434279
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1759720X261434279
    Titles:
      – TitleFull: Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chen YH
      – PersonEntity:
          Name:
            NameFull: Byers Kraus V
      – PersonEntity:
          Name:
            NameFull: Chang YS
      – PersonEntity:
          Name:
            NameFull: Lin TM
      – PersonEntity:
          Name:
            NameFull: Lee HY
      – PersonEntity:
          Name:
            NameFull: Chang CK
      – PersonEntity:
          Name:
            NameFull: Kuo TT
      – PersonEntity:
          Name:
            NameFull: Chen JH
      – PersonEntity:
          Name:
            NameFull: Chang CC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 03
              Text: 2026 Mar 29
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1759-720X
          Numbering:
            – Type: volume
              Value: 18
          Titles:
            – TitleFull: Therapeutic advances in musculoskeletal disease
              Type: main
ResultId 1